# Novel Type 2 Diabetes Mellitus Preventive Therapies

> **NCT02351323** · PHASE1 · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Glutamine (Pharmacological doses)
- **BEHAVIORAL:** Lifestyle change

## Key facts

- **NCT ID:** NCT02351323
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02351323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02351323, "Novel Type 2 Diabetes Mellitus Preventive Therapies". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02351323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*